Equate Kids Daytime Dex Cough Gels

Description

Equate Kids Daytime Dex Gel Chews are formulated as a chewable dosage form specifically designed for pediatric use. Each package contains 16 individual gel chews. The product is intended for the management of symptoms associated with common colds and allergies. The formulation is designed to provide effective relief while being palatable for children.

Uses and Indications

This drug is indicated for the temporary relief of cough associated with minor throat and bronchial irritation, which may occur due to a cold.

There are no teratogenic or nonteratogenic effects associated with this medication.

Dosage and Administration

Adults and children aged 12 years and older are instructed to take 2 chewable tablets every 4 hours, with a maximum dosage of 12 chewable tablets within a 24-hour period. For children aged 6 to 12 years, the recommended dosage is 1 chewable tablet every 4 hours, not to exceed 6 chewable tablets in a 24-hour period.

It is essential that the tablets are chewed thoroughly before swallowing to ensure proper absorption. The use of this medication is not recommended for children under 6 years of age. Healthcare professionals should advise patients to follow these guidelines or any additional instructions provided by their physician.

Contraindications

There are no explicit contraindications identified for this product. However, it is essential to adhere to the recommended dosage guidelines, as exceeding the recommended dosage may pose risks to patient safety.

Warnings and Precautions

It is imperative that this product not be used concurrently with prescription monoamine oxidase inhibitors (MAOIs), which are medications prescribed for depression, psychiatric disorders, or Parkinson's disease. Additionally, this product should not be taken for a minimum of two weeks following the discontinuation of an MAOI. Healthcare professionals should advise patients to consult with their doctor or pharmacist if there is any uncertainty regarding the presence of an MAOI in their current prescription medications.

Patients are advised to discontinue use and seek medical attention if a cough persists for more than seven days, recurs, or is accompanied by symptoms such as fever, rash, or a persistent headache. These symptoms may indicate a serious underlying condition that requires further evaluation.

Currently, there are no specific general precautions or laboratory tests recommended for monitoring associated with the use of this product. However, healthcare providers should remain vigilant and assess the patient's overall health status and any potential interactions with other medications.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product. Serious adverse reactions may occur, particularly in individuals who are currently taking or have recently discontinued a prescription monoamine oxidase inhibitor (MAOI). It is contraindicated to use this product in conjunction with MAOIs or within two weeks of stopping such medication. Patients are advised to consult a healthcare professional if they are uncertain whether their prescription includes an MAOI.

Common adverse reactions may include the need to discontinue use if cough persists for more than seven days, recurs, or is accompanied by fever, rash, or a persistent headache, as these symptoms could indicate a serious underlying condition.

Additionally, patients should seek medical advice before using this product if they have a sodium-restricted diet, experience a cough accompanied by excessive phlegm, or have a persistent or chronic cough related to smoking, asthma, or emphysema. These considerations are important to ensure safe and effective use of the product.

Drug Interactions

The concomitant use of this product with monoamine oxidase inhibitors (MAOIs) is contraindicated. MAOIs are typically prescribed for the treatment of depression, certain psychiatric disorders, or Parkinson's disease. Patients should not take this product while on MAOIs or within 14 days of discontinuing an MAOI. It is essential for patients to consult with a healthcare professional, such as a doctor or pharmacist, to confirm whether their current prescription includes an MAOI before initiating treatment with this product.

Packaging & NDC

Below are the non-prescription pack sizes of Equate Kids Daytime Dex Cough Gels (dextromethorphan). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to 12 years may receive 1 chewable tablet every 4 hours, with a maximum of 6 chewable tablets in a 24-hour period. The use of this medication is not recommended for children under 6 years of age.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits associated with its use during pregnancy and lactation. The safety of this medication in pregnant women has not been established, and caution is advised to ensure the well-being of both the mother and the fetus.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance. Healthcare professionals are advised to contact a Poison Control Center at 1-800-222-1222 for guidance on managing the situation effectively.

Prompt intervention is crucial, as the symptoms of an overdose can vary significantly depending on the substance involved. Therefore, a thorough assessment and appropriate management strategies should be implemented as soon as possible to mitigate potential risks to the patient’s health.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No non-teratogenic effects have been provided in the insert. Additionally, there is no information available regarding nonclinical toxicology or animal pharmacology and toxicology in the insert.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Patients should be informed to stop use and consult a doctor if their cough persists for more than 7 days, tends to recur, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious condition.

It is important to emphasize that patients should not exceed the recommended dosage while using this product. Additionally, healthcare providers should encourage patients to seek medical advice before use if they have a sodium-restricted diet, if their cough is accompanied by excessive phlegm (mucus), or if they experience a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema.

Storage and Handling

The product is supplied in a package configuration that includes NDC numbers relevant to its distribution. It should be stored in a cool, dry place, maintaining a temperature range of 20° to 25°C (68° to 77°F) to ensure optimal stability and efficacy. Proper handling is essential to preserve the integrity of the product, and it should be protected from excessive moisture and heat during storage.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Equate Kids Daytime Dex Cough Gels, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)